Eden Research (LON:EDEN) Stock Price Down 3.3% – What’s Next?

Eden Research plc (LON:EDEN)’s share price was down 3.3% during mid-day trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares changed hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The company’s 50 day moving average is GBX 3.88 and its 200 day moving average is GBX 3.95. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The stock has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92.

Insider Buying and Selling

In other Eden Research news, insider Alexander John Abrey acquired 540,540 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction on Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). 14.02% of the stock is owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.